Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Clin Pharmacol Ther. 2018 Aug 6;105(1):210–218. doi: 10.1002/cpt.1146

Table 3.

Pre-specified time-varying covariates included in the conditional Poisson regression model

Category Component Description Identification
method
Drugs that interact with sulfonylureas ACE inhibitorsa benazepril, enalapril, lisinopril, perindopril, ramipril, captopril, fosinopril, moexipril, quinapril, trandolapril NDC, dispensing date, days' supply
ARBsa losartan, candesartan, valsartan, irbesartan, eprosartan, olmesartan, telmisartan, azilsartan NDC, dispensing date, days' supply
Beta blockersa acebutolol, atenolol, betaxolol, bisoprolol, carteolol, carvedilol, labetalol, metoprolol, nadolol, nebivolol, penbutolol, pindolol, propranolol, sotalol, timolol NDC, dispensing date, days' supply
MAO inhibitorsa isocarboxazid, phenelzine, selegiline, tranylcypromine NDC, dispensing date, days' supply
Quinolonesb cinoxacin, ciprofloxacin, enoxacin, gatifloxacin, gemifloxacin, grepafloxacin, levofloxacin, lomefloxacin, moxifloxacin, nalidixic acid, norfloxacin, ofloxacin, sparfloxacin, trovafloxacin NDC, dispensing date, days' supply
Salicylatesa aspirin, choline salicylate, magnesium salicylate, magnesium salicylate tetrahydrate, salsalate, sodium salicylate NDC, dispensing date, days' supply
Othersa sulfamethoxazole, trimethoprim, haloperidol, quinidine, quinine, pentamidine, chloramphenicol, chloroquine, clofibrate, disopyramide NDC, dispensing date, days' supply
Drugs that can cause hyperglycemia Atypical antipsychoticsa aripiprazole, clozapine, iloperidone, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone NDC, dispensing date, days' supply
Calcineurin inhibitorsa cyclosporine, sirolimus, tacrolimus NDC, dispensing date, days' supply
Corticosteroidsa betamethasone, budesonide, cortisone, dexamethasone, fluodrocortisone, hydrocortisone, methylprednisolone, prednisolone, prednisone, triamcinolone NDC, dispensing date, days' supply
Protease inhibitorsa amprenavir, atazanavir, darunavir, fosamprenavir, indinavir, lopinavir, nelfinavir, ritonavir, saquinavir, tipranavir NDC, dispensing date, days' supply
Retinoida tretinoin, isotretinoin, acitretin NDC, dispensing date, days' supply
Thiazide and thiazide-like diureticsa bendroflumethiazide, benthiazide, chlorothiazide, chlorthalidone, hydrochlorothiazide, hydroflumethiazide, indapamide, methyclothiazide, metolazone, polythiazide, trichlormethiazide NDC, dispensing date, days' supply
Drugs that interact with sulfonylureas CYP2C9 inhibitors fluconazoleb, cotrimoxazoleb, fenofibratea NDC, dispensing date, days' supply
CYP3A4 inhibitors azithromycinb, clarithromycinb, erythromycinb, simvastatina, gemfibrozila NDC, dispensing date, days' supply
Major non-chronic condition that may affect hypoglycemia Acute infectionb acute infection identified at any position of discharge diagnosis on inpatient or outpatient claims ICD-9-CM diagnosis codes, admission or service date
Average daily dose of object drugs* Average daily dose of sulfonylureas and metforminc defined by [(prescription quantity × strength) / (prescription days’ supply)] NDC, dispensing date, days' supply, quantity, strength

NDC: National Drug Code. CYP: cytochrome P450 enzyme. ICD-9-CM: International Classification of Diseases 9th Revision Clinical Modification. CPT: Current Procedural Terminology. HCPCS: Healthcare Common Procedure Coding System. ACE: angiotensin-converting enzyme. ARB: angiotensin II receptor antagonists. MAO: monoamine oxidase.

a

Measured as a day-level binary variable indicating being dispensed on the current day (refers to each day during the observation time as current) or any time during the 31 days prior to the current day.

b

Measured as a day-level binary variable indicating being dispensed on the current day or any time during the 15 days prior to the current day.

c

Measured as a day-level continuous variable on the current day, based on the prescription active on the current day.

*

covariates additionally adjusted in the sensitivity analysis.